Abstract
Previously we demonstrated that circulating peptide YY (PYY), which inhibits pancreatic exocrine secretion, binds to specific receptors in the area postrema (AP); therefore we have tested the hypothesis that the removal of the AP (APX) will alter the effects of PYY on pancreatic secretion in awake rats. One-month after AP lesion or sham lesion, rats were implanted with pancreatic, biliary, duodenal, and intravenous catheters. After recovery from the surgery, unanesthetized rats were infused with vehicle or PYY (30 pmol/kg/hr or 100 pmol/kg/hr) under basal or 2-deoxy-d-glucose (2-DG) stimulated (75 mg/kg, intravenous bolus) conditions. PYY at 30 pmol/kg/hr inhibited basal pancreatic fluid secretion in sham-operated rats, but not APX rats. PYY at 100 pmol/kg/hr stimulated basal pancreatic protein secretion in sham-operated rats, and this effect was also lost in APX rats. PYY at 30 and 100pmol/kg/hr inhibited peak 2-DG stimulated protein secretion to a greater extent in APX rats as compared to sham-operated rats (P < 0.05). Since PYY inhibition of basal pancreatic secretion is AP dependent and inhibition of 2-DG stimulated pancreatic secretion is AP independent, we conclude that the 2-DG pathway of pancreatic secretion differs from the pathway responsible for basal secretion, and that APX potentiates the inhibitory effect of PYY on the 2-DG pathway.
Similar content being viewed by others
REFERENCES
Whitcomb DC: Neuroendocine control of the exocrine pancreas. In GHJ Greeley (ed). Gastrointestinal Endocrinology. Totowa, New Jersey, Humana Press, 1999, pp:243–263
Owyang C: Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am J Physiol 271:G1–G7, 1996
Solomon TE, Walsh JH, Bussjaeger L, Zong Y, Hamilton JW, Ho FJ, Lee TD, Reeve JR Jr: COOH-terminally extended secretins are potent stimulants of pancreatic secretion. Am J Physiol 276:G808–G816, 1999
Deng X, Whitcomb DC: Neurohormonal control of the exocrine pancreas. Curr Opinion Gastroenterol 14:362–368, 1998
Taylor IL, Solomon TE, Walsh JH, Grossman MI: Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. Gastroenterology 76:524–528, 1979
Greeley GHJ, Jeng YJ, Gomez G, Hashimoto T, Hill FLC, Kern K, Kurosky T, Chuo HF, Thompson JC: Evidence for regulation of peptide YY release by the proximal gut. Endocrinology 124:1438–1443, 1989
Aponte GW, Park K, Hess R, Garcia R, Taylor IL: Mealinduced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J 3:1949–1955, 1989
Teyssen S, Grandt D, Niebergall-Roth E, Schimiczek M, Goebell H, Eysselein VE, Reeve JR Jr Singer MV: Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors. Pancreas 13:80–88, 1996
Hernandez EJ, Whitcomb DC, Vigna SR, Taylor IL: Saturable binding of circulating peptide YY in the dorsal vagal complex of rats. Am J Physiol 266:G511–G516, 1994
Goumain M, Voisin T, Lorinet AM, Laburthe M: Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochem Biophys Res Commun 247: 52–56, 1998
Louie DS, Williams JA, Owyang C: Action of pancreatic polypetide on rat pancreatic secreton: In vivo and in vitro. Am J Physiol 249:G489–G495, 1985
Guarita DR, Deng X, Huh YB, Wood PG, Reeve JR Jr, Whitcomb DC: PYY regulates pancreatic exocrine secretion through multiple receptors in the awake rat. Dig Dis Sci 45:1696–1702, 2000
Kalia M, Sullivan JM: Brainstem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 211:248–265, 1982
Whitcomb DC, Taylor IL, Vigna SR: Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. Am J Physiol 260:G687–G691, 1990
Whitcomb DC, Puccio AM, Vigna SR, Taylor IL, Hoffman GE: Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res 760:137–149, 1997
Whitcomb DC, Yin M, Curtis J, Puccio A, Reeve J, Sved AF: Centrally mediated pancreeatic secretion is stimulated through the Y1 receptor and inhibited through Y2 receptor. Gastroenterol 108:A400, 1995
Deng X, Guarita DR, Kreiss C, Wood PG, Pedroso MAR, Sved AF, Whitcomb DC: PYY inhibits CCK-stimulated pancreatic secretion through the Area Postrema in unanesthetized rats. Am J Physiol 281:R645–R653, 2001
Curtis KS, Huang W, Sved AF, Verbalis JG, Stricker EM: Impaired osmoregulatory responses in rats with area postrema lesions. Am J Physiol 277:R209–R219, 1999
Jin H, Cai L, Lee K, Chang TM, Li P, Wagner D, Chey WY: A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterol 105:208–215, 1993
Rinaman L, Miselis RR: The organization of vagal innervation of rat pancreas using cholera toxin-horseradish peroxidase conjugate. J Auton Nerv Syst 21:109–125, 1987
Putnam WS, Liddle RA, Williams JA: Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol 256:G698–G703, 1989
Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR: Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterol 89:494–499, 1985
Pappas TN, Debas HT, Goto Y, Taylor IL: Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 248:G118–G123, 1985
Tohno H, Sarr MG, DiMagno EP: Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility. Gastroenterol 109:1977–1985, 1995
Holst JJ, Rasmussen TN, Harling H, Schmidt P: Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. Pancreas 8:80–87, 1993
Sheikh SP, Roach E, Fuhlendorff J, Williams JA: Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am J Physiol 260:G250–G257, 1991
Roze C, de La Tour J, Chariot J, Souchard M, Vaille C, Debray C: Pancreatic stimulation by 2-deoxy-D-glucose in the rat: A study of neural and hormonal mechanism. Gastroenterol Clin Biol 1:435–446, 1977
Kobashi M, Adachi A: Effect of topical administration of glucose on neurons innervating abdominal viscera in dorsal motor nucleus of vagus in rats. Jpn J Physiol 44:729–734, 1994
Masuda M, Kanai S, Miyasaka K: Central somatostatin prevents vagal efferent nerve excitation produced by TRH but not by 2-deoxy-D-glucose. Am J Physiol 272:G351–G356, 1997
Deng X, Guarita DR, Wood PG, Kreiss C, and Whitcomb DC: PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG stimulated pathways in awake rats. Dig Dis Sci 46:156–165, 2001
Konturek SJ, Bilski J, Pawlik W, Tasler J, Domschke W: Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs. Gastroenterol 94:266–273, 1988
Nagain C, Chariot J, Roze C: Differential effects of peptide YY, neuropeptide Y, and sigma ligands on neurally stimulated external pancreatic secretion in the rat. Pancreas 10:123–130, 1995
Yang H, Kawakubo K, Tache Y: Intracisternal PYY increases gastric mucosal resistance: Role of cholinergic, CGRP, and NO pathways. Am J Physiol 277:G555–G562, 1999
Ericsson A, Arias C, Sawchenko PE: Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 17:7166–7179, 1997
Deng X, Wood PG, Sved AF, Whitcomb DC: The area postrema lesions alter the inhibitory effects of peripherally infused pancreatic polypeptide on pancreatic secretion. Brain Res 902:18–29, 2001
Okumura TP, Pappas TN, Taylor IL: Pancreatic polypeptide microinjection into the dorsal motor nucleus inhibits pancreatic secretion in rats. Gastroenterol 108:1517–1525, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deng, X., Guarita, D.R., Pedroso, M.R. et al. Area Postrema Lesion Alters the Effects of Peptide YY on 2-DG-Stimulated Pancreatic Exocrine Secretion. Dig Dis Sci 46, 2460–2469 (2001). https://doi.org/10.1023/A:1012380004736
Issue Date:
DOI: https://doi.org/10.1023/A:1012380004736